Article Details

Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor ...

Retrieved on: 2021-02-16 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor .... View article details on hiswai:

Excerpt

("Iterion"), a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, announced today that it has raised $17 million ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up